Biogen Exits Joint Venture As Samsung Biologics Buys Out Bioepis

Sale Price Of $2.3bn To Be Paid Over Next Two Years

 
• By Chloe Kent

Biogen’s stake in Samsung Bioepis has been fully acquired by former partner Samsung Biologics, following an announcement of the deal in January.

Hand separating puzzle pieces
Biogen announced its decision to sell its stake in January • Source: Alamy

More from Deals

More from Business